Lawrence Steinman - Jun 1, 2023 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role: Director
Signature: /s/ Lawrence Steinman, M.D.
Stock symbol: ATNF
Transactions as of: Jun 1, 2023
Transactions value $: $22,068
Form type: 4
Date filed: 6/2/2023, 08:00 AM
Previous filing: Nov 28, 2022
Next filing: Jun 6, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATNF	Common Stock	Purchase	$22.1K	+18K	+59.74%	$1.23	48.1K	Jun 1, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $1.15 to $1.26. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Content

This transaction was executed in multiple trades at prices ranging from $1.15 to $1.26. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.